Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Lixte Biotechnology Holdings Inc’s stock clocked out at $2.53, up 12.95% from its previous closing price of $2.24. In other words, the price has increased by $12.95 from its previous closing price. On the day, 1.47 million shares were traded. LIXT stock price reached its highest trading level at $2.73 during the session, while it also had its lowest trading level at $2.3001.
Ratios:
To gain a deeper understanding of LIXT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.26 and its Current Ratio is at 4.26. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIXT now has a Market Capitalization of 6975184 and an Enterprise Value of 4544390.
Stock Price History:
The Beta on a monthly basis for LIXT is 0.10, which has changed by 0.11946905 over the last 52 weeks, in comparison to a change of 0.10500872 over the same period for the S&P500. Over the past 52 weeks, LIXT has reached a high of $4.25, while it has fallen to a 52-week low of $0.64. The 50-Day Moving Average of the stock is 94.81%, while the 200-Day Moving Average is calculated to be 53.12%.
Shares Statistics:
It appears that LIXT traded 1.96M shares on average per day over the past three months and 11949770 shares per day over the past ten days. A total of 2.68M shares are outstanding, with a floating share count of 2.08M. Insiders hold about 22.33% of the company’s shares, while institutions hold 11.18% stake in the company. Shares short for LIXT as of 1749772800 were 4456 with a Short Ratio of 0.00, compared to 1747267200 on 32595. Therefore, it implies a Short% of Shares Outstanding of 4456 and a Short% of Float of 0.16.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
